Need access to NeoLink? Contact your Sales rep or our Client Services team at 866.776.5907, Option 3
July 10, 2025
Effective July 30th, 2025, our existing liquid biopsy tests will be retired in favor of our new, upgraded liquid biopsy test, NEO | PanTracer™ LBx.
Tests to be retired:
- InVisionFirst®- Lung
- NeoLAB® Solid Tumor
Replacement test:
NEO | PanTracer LBx is a comprehensive genomic profiling liquid biopsy test assessing over 500 genes by ctDNA sequencing. PanTracer LBx contains broader, more updated gene content, which better aligns with clinical practice guidelines and is available for advanced stage solid tumor patients. For additional information on PanTracer LBx, please visit our website.
We’re excited to announce PanTracer Tissue (formerly Neo Comprehensive – Solid Tumor), is now available to order, along with an expanded offering for ovarian cancer patients: PanTracer Tissue + HRD.
The PanTracer portfolio reflects our commitment to evolving with the needs of oncology care—offering tests that are practical, powerful, and designed to support real-world clinical decisions.
PanTracer Tissue offers a tissue-based CGP approach, providing deep insights into tumor genome from solid-tumor biopsy samples, helping oncologists make precise, actionable therapy decisions.
PanTracer Tissue + HRD is a single, advanced assay designed specifically for ovarian cancer, uniquely combining Comprehensive Genomic Profiling (CGP) and an advanced HRD assessment in one streamlined solution. Our advanced HRD assessment covers BRCA1/2 mutation status and genomic instability (GIS), including LOH, TAI, and LST, to guide personalized treatment decisions.
We’re proud to share PanTracer Tissue and PanTracer Tissue + HRD with you. For more info, please contact your local NeoGenomics Sales Representative or visit our website.
Learn more about the PanTracer Portfolio and order today!
Orders submitted for Neo Comprehensive – Solid Tumor will automatically convert to PanTracer Tissue.
CGP = comprehensive genomic profiling; GIS = genomic instability score; HRD = homologous recombination deficiency; LOH = loss of heterozygosity; LST = large-scale state transitions; TAI = telomeric allelic imbalance
US Independence Day Schedule
Logistics: FedEx will be closed for the Independence Day holiday (no pickups or deliveries) on Friday, July 4th. Any specimens shipped from client locations on Thursday, July 3rd will have an expected delivery day of Saturday, July 5th. Though regularly scheduled daily pick-ups will not occur on July 4th, we are available to pick up STAT cases or specimens where viability is a concern. For these cases, please call Client Services at 866.776.5907, option 1 for assistance.
Operations: NeoGenomics Operations will continue to process samples on Friday, July 4th to deliver quality test results with no delays to turnaround time caused by the holiday.
Client Services: Client Services will be closed on Friday, July 4th for urgent cases however representatives will be available to provide assistance as needed. Please call 866.776.5907, and press option 3.
Billing: Please call 866.776.5907, press option 2, and follow the prompts to leave a message. Your call will be returned on Monday, July 7th.